Pascal to be voted out by board

Discussion in 'AstraZeneca' started by anonymous, Nov 19, 2017 at 9:00 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Hang on folks! Something to be thankful for soon!

    Swedish government and all of the socialist benefits that come from a healthy AZ are about to come into play.

    Fuck the French!
     

  2. anonymous

    anonymous Guest

    Zzzzz
     
  3. anonymous

    anonymous Guest

    Plenty of one to snooze in while you and your master as shit canned.

    You have laundered enough from shareholders.
     
  4. anonymous

    anonymous Guest

    Frenchie is staying.
     
  5. anonymous

    anonymous Guest

    Frenchies pool boy needs an assistant, why don't you apply ?
     
  6. anonymous

    anonymous Guest

    Because working for his pool boy will mean 10-15 in the federal penal system.
     
  7. anonymous

    anonymous Guest

    Pascal will be forced to get $500 Million in budget cuts for 2018. $350 Million coming through layoffs and another $150 Million as part of divestment. Watch the news folks!
     
  8. anonymous

    anonymous Guest

    Believe it when you see it!
     
  9. anonymous

    anonymous Guest

    That is the low end number or best case scenario. This could be much worse.
     
  10. anonymous

    anonymous Guest

    Remember the plan was to cut $1.7 Billion by the end of this year. I wonder if he met the goal yet.
     
  11. anonymous

    anonymous Guest

    He did not. Off the mark by $500MM
     
  12. anonymous

    anonymous Guest

    Try off by $1 BILLION! He cut $700 MILLION last year.
     
  13. anonymous

    anonymous Guest

    Pascal cut less than $200 Million in salary and benefits last year. Please provide proof of the other $500 Million in cuts?

    Most of those cuts were shifted to Diabetes to overspend on access meals and speaker programs. Huge waste of resources. Simple contracting tweaks would be been more efficient and more effective.

    Not sure what the pension and healthcare cuts to retirees are going to save. If anyone has an estimate, please provide.

    Pascal needs to cut about 1500 field sales personnel. He also needs to cut about 1500 non-commercial personnel. Most coming from manufacturing, medical, and R&D. Most medical directors are worthless.
     
  14. anonymous

    anonymous Guest

    French and of short stature to boot!
     
  15. anonymous

    anonymous Guest

    The board isn't the smartest group of individuals to begin with.
    After all, they've let him hang on this long,right?
    All the promises, return to growth, 45B by 2023...blah blah.
    Oh, they let the Phizer buyout opportunity slip by as well.
    Don't give them too much credit.
     
  16. anonymous

    anonymous Guest

    Anyone with half a brain could see that $45 Billion was a bullshit target. Sales will be no more than $25 Billion. Remember Pascal has given half of the most promising meds in the pipeline away. Creative math will still include the half shared as topline sales.
     
  17. anonymous

    anonymous Guest

    Pascal's not going anywhere........YOU are!!
     
  18. anonymous

    anonymous Guest

    Couldn’t be so lucky!
     
  19. anonymous

    anonymous Guest

    $45b by 2023 out of reach. we need growth rate of 15% per year to make it by end of 2023. 2018 forecast single digits revenue increase not good start. our pipeline might be good but not moving fast enough.
     
  20. anonymous

    anonymous Guest

    Irrelevant promise from him. Even more disturbing, it's the board with the final say. They are the ones with the wool over their eyes. Pascal must be a greeeaaat salesman to have stayed on this long. Definitely sold the board some miracle potion.